vs
Cytek Biosciences, Inc.（CTKB）与花花公子（PLBY）财务数据对比。点击上方公司名可切换其他公司
Cytek Biosciences, Inc.的季度营收约是花花公子的1.8倍（$62.1M vs $34.9M），花花公子净利率更高（10.3% vs -70.9%，领先81.2%），Cytek Biosciences, Inc.同比增速更快（8.1% vs 4.2%），花花公子自由现金流更多（$1.1M vs $-1.8M），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs 11.0%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
花花公子集团（Playboy, Inc.）起源于1953年由休·海夫纳联合合伙人在美国芝加哥创立，初始部分资金来自海夫纳母亲提供的1000美元贷款，是美国知名生活方式与娱乐内容品牌，旗下核心《花花公子》杂志同时发行电子版与纸质版。
CTKB vs PLBY — 直观对比
营收规模更大
CTKB
是对方的1.8倍
$34.9M
营收增速更快
CTKB
高出3.9%
4.2%
净利率更高
PLBY
高出81.2%
-70.9%
自由现金流更多
PLBY
多$2.9M
$-1.8M
两年增速更快
CTKB
近两年复合增速
11.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $34.9M |
| 净利润 | $-44.1M | $3.6M |
| 毛利率 | 52.9% | 73.3% |
| 营业利润率 | -9.0% | 7.9% |
| 净利率 | -70.9% | 10.3% |
| 营收同比 | 8.1% | 4.2% |
| 净利润同比 | -557.1% | 128.6% |
| 每股收益（稀释后） | — | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBPLBY
| Q4 25 | $62.1M | $34.9M | ||
| Q3 25 | $52.3M | $29.0M | ||
| Q2 25 | $45.6M | $28.1M | ||
| Q1 25 | $41.5M | $28.9M | ||
| Q4 24 | $57.5M | $33.5M | ||
| Q3 24 | $51.5M | $29.4M | ||
| Q2 24 | $46.6M | $24.9M | ||
| Q1 24 | $44.9M | $28.3M |
净利润CTKBPLBY
| Q4 25 | $-44.1M | $3.6M | ||
| Q3 25 | $-5.5M | $460.0K | ||
| Q2 25 | $-5.6M | $-7.7M | ||
| Q1 25 | $-11.4M | $-9.0M | ||
| Q4 24 | $9.6M | $-12.5M | ||
| Q3 24 | $941.0K | $-33.8M | ||
| Q2 24 | $-10.4M | $-16.7M | ||
| Q1 24 | $-6.2M | $-16.4M |
毛利率CTKBPLBY
| Q4 25 | 52.9% | 73.3% | ||
| Q3 25 | 52.7% | 76.0% | ||
| Q2 25 | 52.3% | 65.4% | ||
| Q1 25 | 48.6% | 68.6% | ||
| Q4 24 | 58.5% | 70.8% | ||
| Q3 24 | 56.3% | 61.0% | ||
| Q2 24 | 54.6% | 67.8% | ||
| Q1 24 | 51.3% | 55.8% |
营业利润率CTKBPLBY
| Q4 25 | -9.0% | 7.9% | ||
| Q3 25 | -17.6% | 4.7% | ||
| Q2 25 | -23.3% | -20.9% | ||
| Q1 25 | -36.1% | -21.7% | ||
| Q4 24 | 5.2% | -13.3% | ||
| Q3 24 | -8.2% | -96.0% | ||
| Q2 24 | -18.3% | -37.0% | ||
| Q1 24 | -23.9% | -31.5% |
净利率CTKBPLBY
| Q4 25 | -70.9% | 10.3% | ||
| Q3 25 | -10.5% | 1.6% | ||
| Q2 25 | -12.2% | -27.3% | ||
| Q1 25 | -27.5% | -31.3% | ||
| Q4 24 | 16.8% | -37.4% | ||
| Q3 24 | 1.8% | -114.7% | ||
| Q2 24 | -22.4% | -66.9% | ||
| Q1 24 | -13.8% | -58.1% |
每股收益（稀释后）CTKBPLBY
| Q4 25 | — | $0.05 | ||
| Q3 25 | — | $0.00 | ||
| Q2 25 | — | $-0.08 | ||
| Q1 25 | — | $-0.10 | ||
| Q4 24 | — | $-0.13 | ||
| Q3 24 | — | $-0.45 | ||
| Q2 24 | — | $-0.23 | ||
| Q1 24 | — | $-0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $37.8M |
| 总债务越低越好 | — | $174.2M |
| 股东权益账面价值 | $341.7M | $18.4M |
| 总资产 | $461.5M | $292.4M |
| 负债/权益比越低杠杆越低 | — | 9.48× |
8季度趋势，按日历期对齐
现金及短期投资CTKBPLBY
| Q4 25 | $90.9M | $37.8M | ||
| Q3 25 | $93.3M | $27.5M | ||
| Q2 25 | $75.5M | $19.6M | ||
| Q1 25 | $95.3M | $23.7M | ||
| Q4 24 | $98.7M | $30.9M | ||
| Q3 24 | $162.3M | $9.5M | ||
| Q2 24 | $177.9M | $16.9M | ||
| Q1 24 | $168.8M | $19.0M |
总债务CTKBPLBY
| Q4 25 | — | $174.2M | ||
| Q3 25 | — | $176.8M | ||
| Q2 25 | — | $177.5M | ||
| Q1 25 | — | $176.3M | ||
| Q4 24 | — | $176.6M | ||
| Q3 24 | — | $200.0M | ||
| Q2 24 | — | $196.3M | ||
| Q1 24 | — | $193.4M |
股东权益CTKBPLBY
| Q4 25 | $341.7M | $18.4M | ||
| Q3 25 | $378.6M | $3.8M | ||
| Q2 25 | $377.6M | $-17.5M | ||
| Q1 25 | $379.6M | $-11.4M | ||
| Q4 24 | $395.7M | $-7.7M | ||
| Q3 24 | $385.5M | $-15.7M | ||
| Q2 24 | $389.1M | $15.7M | ||
| Q1 24 | $392.6M | $29.5M |
总资产CTKBPLBY
| Q4 25 | $461.5M | $292.4M | ||
| Q3 25 | $494.9M | $278.3M | ||
| Q2 25 | $493.3M | $264.1M | ||
| Q1 25 | $482.6M | $270.6M | ||
| Q4 24 | $499.5M | $284.7M | ||
| Q3 24 | $491.2M | $271.5M | ||
| Q2 24 | $483.7M | $301.8M | ||
| Q1 24 | $492.1M | $309.1M |
负债/权益比CTKBPLBY
| Q4 25 | — | 9.48× | ||
| Q3 25 | — | 46.86× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.51× | ||
| Q1 24 | — | 6.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $1.4M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $1.1M |
| 自由现金流率自由现金流/营收 | -2.9% | 3.2% |
| 资本支出强度资本支出/营收 | 1.6% | 0.8% |
| 现金转化率经营现金流/净利润 | — | 0.39× |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $-1.0M |
8季度趋势，按日历期对齐
经营现金流CTKBPLBY
| Q4 25 | $-771.0K | $1.4M | ||
| Q3 25 | $-3.9M | $10.1M | ||
| Q2 25 | $108.0K | $-3.9M | ||
| Q1 25 | $-125.0K | $-7.6M | ||
| Q4 24 | $2.0M | $161.0K | ||
| Q3 24 | $13.2M | $-6.5M | ||
| Q2 24 | $6.2M | $-3.0M | ||
| Q1 24 | $4.0M | $-9.8M |
自由现金流CTKBPLBY
| Q4 25 | $-1.8M | $1.1M | ||
| Q3 25 | $-4.6M | $9.8M | ||
| Q2 25 | $-1.5M | $-4.3M | ||
| Q1 25 | $-974.0K | $-7.7M | ||
| Q4 24 | $1.1M | $-401.0K | ||
| Q3 24 | $12.2M | $-7.0M | ||
| Q2 24 | $5.2M | $-3.7M | ||
| Q1 24 | $3.4M | $-10.3M |
自由现金流率CTKBPLBY
| Q4 25 | -2.9% | 3.2% | ||
| Q3 25 | -8.7% | 33.8% | ||
| Q2 25 | -3.2% | -15.2% | ||
| Q1 25 | -2.3% | -26.5% | ||
| Q4 24 | 1.9% | -1.2% | ||
| Q3 24 | 23.7% | -23.7% | ||
| Q2 24 | 11.0% | -14.8% | ||
| Q1 24 | 7.6% | -36.5% |
资本支出强度CTKBPLBY
| Q4 25 | 1.6% | 0.8% | ||
| Q3 25 | 1.3% | 1.1% | ||
| Q2 25 | 3.5% | 1.4% | ||
| Q1 25 | 2.0% | 0.1% | ||
| Q4 24 | 1.6% | 1.7% | ||
| Q3 24 | 2.0% | 1.5% | ||
| Q2 24 | 2.3% | 2.6% | ||
| Q1 24 | 1.3% | 2.1% |
现金转化率CTKBPLBY
| Q4 25 | — | 0.39× | ||
| Q3 25 | — | 22.02× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
PLBY
| Transferred At Point In Time | $22.2M | 64% |
| Trademark Licensing | $6.5M | 19% |
| Related Party | $5.0M | 14% |
| Other | $1.1M | 3% |
